Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
about
Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere's Disease [corrected].Hyaluronic acid enhances gene delivery into the cochlea.Issues, indications, and controversies regarding intratympanic steroid perfusionLong-term prognosis of low-frequency hearing loss and predictive factors for the 10-year outcome.Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.A review on the use of hyaluronic acid in tympanic membrane wound healing.Prognostic implications of and audiometric evidence for hearing fluctuation in Meniere's disease.Local treatment of the inner ear: a study of three different polymers aimed for middle ear administration.Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.Therapeutic effect of Intra-Tympanic Dexamethasone-Hyaluronic Acid Combination in Sudden Sensorineural Hearing LossTrial of Chinese medicine Wu-Ling-San for acute low-tone hearing loss.Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.Hearing preservation using topical dexamethasone alone and associated with hyaluronic acid in cochlear implantation.The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial.[Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss.Intratympanic steroids for idiopathic sudden sensorineural hearing loss.
P2860
Q30466045-AAAD5A50-A8D6-4F7B-9CBE-3C6D89F7CC15Q33867906-5E6BC9DF-F235-40EA-A566-EEE557EC86ABQ35823878-465B1A17-9F1F-4363-A6BF-D7185CA1563CQ37146991-396C8B80-391B-4D60-BCED-A2F72F7EE090Q37715423-E6616349-2F1E-414F-8C80-DCC1D3134183Q37919754-47B345AB-2F19-4595-B4C9-6B2A509B1863Q37953440-F2FF9238-0BAD-4684-B2B7-50A80DEDDF47Q38581805-C46C22EE-2DB2-4F85-B309-23B0CAAC3096Q40293997-FA961568-10F9-4B16-A334-0C764FBB3581Q41372707-51997752-877B-4B95-9347-D48F1D26F045Q41685344-A05B4D62-28BD-4F6C-8599-2DD6FACB5DD1Q45818898-0B86E542-ED8F-4EF1-8559-2A9B51EB8890Q48564168-97EF51B9-1500-48F0-A7B3-2F01388B0BBBQ50353016-DB21E6F6-44DF-455C-9C0C-3B53788C7A14Q50357747-D444E08D-7078-4E8E-A326-0B04A045EE1EQ50432428-E7491701-3E95-4D64-9CDE-CC9CC38C1036Q50432832-1E8DDAC1-3740-438D-BF0F-B33F0606F321Q50435385-1366D4E9-4F03-416B-AA64-A34403988752Q50457597-F020FFD1-3992-450B-8CE5-6FE10F1FF6C0
P2860
Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@en
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@nl
type
label
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@en
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@nl
prefLabel
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@en
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@nl
P2093
P1476
Intratympanic dexamethasone an ...... en sensorineural hearing loss.
@en
P2093
Anja Victor
Oksana A Selivanova
Ronald G Amedee
P304
P356
10.1097/01.MAO.0000185050.69394.48
P577
2005-09-01T00:00:00Z